Metraipolis › archive › dc_b2ceddd38294

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey — Europe PMC PMID:41532360

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/41532360
DOI: 10.1002/hon.70167
License (as archived): solo-consultazione
Archived: 2026-11-07T04:30:50.595Z
SHA-256 of the archived text: 5aae63ee4ac14e2462ba6c54d52548c3dd0fc32e23c0388768fbb826b0bf82da
Stable URL of this page: https://metraipolis.com/documento/dc_b2ceddd38294

How to cite

TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey — Europe PMC PMID:41532360 — Europe PMC (en), https://europepmc.org/article/MED/41532360 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b2ceddd38294 (Metraipolis archive dc_b2ceddd38294, sha256 5aae63ee4ac14e2462ba6c54d52548c3dd0fc32e23c0388768fbb826b0bf82da)

BibTeX

@misc{dcb2ceddd38294,
  title = {TALOs, Fill the Gap: Tafasitamab and Lenalidomide in Diffuse Large B-Cell Lymphoma in the Real-Life Patient Journey — Europe PMC PMID:41532360},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41532360},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b2ceddd38294; sha256 5aae63ee4ac14e2462ba6c54d52548c3dd0fc32e23c0388768fbb826b0bf82da},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41532360. Agents can read the archived copy with the MCP tool read_document.